Nuklearmedizin 1984; 23(01): 09-14
DOI: 10.1055/s-0038-1624159
Originalarbeiten - Original Articles
Schattauer GmbH

Non-Specific Tumor-Seeking Radiopharmaceuticals–Report and Future Aspects[*]

Unspezifische Radiopharmaka in der Tumordiagnostik–Bericht und zukünftige Aspekte
L. J. Anghileri
1   From the Nuclear Medicine Service, Faculty of Medicine B, University of Nancy, Nancy, France
› Author Affiliations
Further Information

Publication History

Received: 10 October 1983

Publication Date:
10 January 2018 (online)

Summary

A review is made of some currently held views regarding the mechanism of uptake of non-specific tumor-seeking labelled compounds, with special reference to the role of cell membranes and the transfer mechanisms across such membranes. Results with various radiopharmaceuticals used in tumor scintigraphy are discussed and some suggestions are made for possibly profitable research to be done in that area.

Zusammenfassung

Es wird eine Übersicht über einige derzeit gängige Ansichten bezüglich der Mechanismen der Tumorspeicherung unspezifischer markierter Verbindungen mit besonderer Berücksichtigung der Rolle der Zellmembranen und der Transfervorgänge durch solche Membranen gegeben. Die Ergebnisse mit verschiedenen, in der Tumorszintigraphie verwendeten Radiopharmaka werden diskutiert und einige Vorschläge für möglicherweise gewinnbringende Studien auf diesem Gebiet gemacht.

* 3rd International Symposium on Radiopharmacology, Freiburg i. Br., September 1983.


 
  • References

  • 1 Abrams D. N., Knaus E. E., Lentle B. C. et al. Tumor uptake of radiolabeled pyrimidine bases and nucleosides in animal models II. 6-(3H)-5-Fluoro-2-deoxyuridine. Int. J. nucl. Med. Biol 06: 103 1979;
  • 2 Anghileri L. J. The mechanism of accumulation of radiogallium and radiolanthanides in tumors. J. nucl. Biol. Med 17: 111 1973;
  • 3 Anghileri L. J., Dermietzel R, Heidbreder M. On the role of tumor cell surface in the accumulation of radioisotopes. Nucl. Med 15: 242 1976;
  • 4 Anghileri L. J., Robert J. Isomorphous ionic replacement: Experimental evidence for the hypothesis proposed to explain gallium-67 accumulation. J. nucl. Med 26: 113 1982;
  • 5 Anghileri L. J., Crone M. C., Marchai C. et al. 67Ga and 59Fe uptake by tumor cells treated with hyperthermia or hyperthermia plus lanthanum. Eur. J. nucl. Med 08: 255 1983;
  • 6 Chadwick Κ.-.H, Leenhouts H. P., Szumiel I. An analysis of the interaction of a platinum complex and radiation with CHO cells using the molecular theory of cell survival. Int. J. Radiat. Biol 30: 511 1976;
  • 7 Danishefsky I, Oppenheimer E. T., Heritier-Warkins O. et al. Mucopolysaccharides in animal tumors. Cancer Res 26: 229 1966;
  • 8 Eddeston A. L., Rake M. O., Pagaltsos A. P. et al. 75Se-selenomethionine in the scintiscan diagnosis of primary hepatocellular carcinoma. Gut 12: 245 1971;
  • 9 Hevesy G. In: Radioactive Indicators. Chapt. 6. International Publishers; London; 1948.
  • 10 Hunter W. W., de Kock H. W. 111In for tumor localization. J. nucl. Med 10: 343 1969;
  • 11 Ito Y, Okuyama S, Miyagi T. et al. Tumor deposition of 111ln studied in the rabbit. Sei. Rep. Res. Inst. Tohoku Univ. C 19: 146 1972;
  • 12 Ito Y, Okuyama S, Takahashi K. et al. Role of inflammation in tumor accretion of radiopharmaceuticals. In: Radioisotopic Methods in Tumor Diagnosis. Kakehi H, Orii H. (eds.), 27 Tokyo Inst: Medical Sciences, Tokyo; 1977.
  • 13 Ito Y, Muranaka A, Harada T. et al. Experimental studies on tumor affinity of 201Tl-chloride. Eur. J. nucl. Med 03: 81 1978;
  • 14 Low-Beer B. V. A., Bell H. G., McCorkle H. J. et al. Measurement of radioactive phosphorus in breast tumors in situ; a possible diagnostic procedure. Radiology 47: 492 1946;
  • 15 Parker S, Lambrecht R. M., Wolf A. P. Lead-203 Tris as a melanoma localizing agent. J. nucl. Med 16: 556 1975;
  • 16 Pastakia B, Lieberman L. M., Gatley S. J. et al. Tissue distribution of copper-labeled 3-Ethoxy-2-oxobutyraldehyde bis-(Thiosemicarbazone) (Cu-64KTS) in mice and rats. J. nucl. Med 21: 67 1980;
  • 17 Pauling L. In: The Nature of the Chemical Bond. p. 3. Cornell Univ. Press Ithaca; N.Y: 1960.
  • 18 Proffitt R. T., Williams L. E., Presant C. E. et al. Liposomal blockade of the reticuloendothelial system: Improved tumor imaging with small unilamellar vesicles. Nature (London) 220: 502 1983;
  • 19 Raynaud C, Comar D. Tumor localization using radiomercury labeled compounds. In: Tumor Localization with Radioactive Agents. Advisory Group Meeting, Vienna, p. 57. Int. Atomic Energy Agency; Vienna: 1976.
  • 20 Rosemberg B, Van Camp I, Trosko J. E. et al. Platinum compounds: a new class of potent antitumor agents. Nature (London) 222: 385 1976;
  • 21 Van der Werff J. T. Gamma encephalography with radioactive bismuth-206. Acta Radiol. Diagn 04: 403 1966;
  • 22 Winzler R. J. Carbohydrates in cell surfaces. Int. Rev. Cytol 29: 77 1970;
  • 23 Winzler R. J., Bekesi J. G. Glyco- proteins in relation to cancer. Methods Cancer Res 02: 159 1967;
  • 24 Winzler L, Fuhrer J. P., Buch C. A. Surface glycoproteins of cells before and after transformation by oncogenic viruses. Fed. Proc 32: 80 1973;